KLRK1 and neoplasm: NKG2D is a typical activating receptor whose ligands are only generally expressed on the surface of abnormal cells such as tumor or stressed cells and can activate the ability of NK cells to kill abnormal cells upon binding to the NKG2D ligands (NKG2DL) (16).